Anti human immunodeficiency virus-1 (HIV-1) agents 1. discovery of benzyl phenyl ethers as new HIV-1 inhibitors in vitro

Chemical and Pharmaceutical Bulletin

Volumn 57, Issue 1, 2009, Pages 84-86

  Dai, Hui Ling ^a   Liu, Wu Qing ^b   Xu, Hui ^a   Yang, Liu Meng ^b   Lv, Min ^a   Zheng, Yong Tang ^b  

^a NORTHWEST A F UNIVERSITY   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

Benzyl phenyl ether; Human immunodeficiency virus; Inhibitor

Indexed keywords

4 NITROBENZYL PHENYL ETHER; BENZYL PHENYL ETHER; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION;

ANTI-HIV AGENTS; CELL LINE; HIV-1; HUMANS; MOLECULAR STRUCTURE; PHENYL ETHERS;

EID: 58849100982     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.57.84     Document Type: Article

References (25)

1. Johston M. I., Hoth D. F., Science, 260, 1286-1293 (1993).
2. Chiang C. C., Mouscadet J. F., Tsai H. J., Liu C. T., Hsu L. Y., Chem. Pharm. Bull., 55, 1740-1743 (2007).
3. Su C. X., Mouscadet J. F., Chiang C. C., Tsai H. J., Hsu L. Y., Chem. Pharm. Bull., 54, 682-686 (2006).
4. Ji L., Chen F. E., Feng X. Q., de Clercq E., Balzarini J., Pannecouque C., Chem. Pharm. Bull., 54, 1248-1253 (2006).
5. Maruyama T., Kozai S., Demizu Y., Witvrouw M., Pannecouque C., Balzarini J., Snoecks R., Andrei G., de Clercq E., Chem. Pharm. Bull., 54, 325-333 (2006).
6. Klis T., Serwatowski J., Tetrahedron Lett., 48, 1169-1173 (2007).
7. Chodakowski J., Klis T., Serwatowski J., Tetrahedron Lett., 46, 1963-1965 (2005).
8. Maiti A. K., Martinez R., Mestres R., Tortajada A., Villar F., Tetrahedron, 57, 3397-3401 (2001).
9. Xu H., Liu W. Q., Fan L. L., Chen Y., Yang L. M., Lv L., Zheng Y. T., Chem. Pharm. Bull., 56, 720-722 (2008).
10. Xu H., Desrivot J., Bories C., Loiseau P. M., Franck X., Hocquemiller R., Figadere B., Bioorg. Med. Chem. Lett., 16, 815-820 (2006).
11. Xu H., Jian K. Z., Guan Q., Ye F., Lv M., Chem. Pharm. Bull., 55, 1755-1757 (2007).
12. Xu H., Zhang X., Tian X., Lu M., Wang Y. G., Chem. Pharm. Bull., 50, 399-402 (2002).
13. Xu H., Fan L. L., Chem. Pharm. Bull., 56, 1496-1498 (2008).
14. Xu H., Zhang L., Su, B. F., Zhang X., Tian X., Heterocycles, published online, 28th June, 2008.
15. Lourenco N. M. T., Afonso C. A. M., Tetrahedron, 59, 789-794 (2003).
16. Huston R. C., J. Am. Chem. Soc., 55, 4639-1643 (1933).
17. Majumder P. L., J. Indian Chem. Soc., 66, 673-680 (1989).
18. Maslak P., Guthrie R. D., J. Am. Chem. Soc., 108, 2628-2636 (1986).
19. Huston R. C., Houk A. L., J. Am. Chem. Soc., 54, 1506-1510 (1932).
20. Wen X. M., J. Chem. Res., 10, 663-664 (2005).
21. Forrester J., Jones R. V. H., Newton L., Preston P. N., Tetrahedron, 57, 2871-2884 (2001).
22. Lyman J. A., Reid E. E., J. Am. Chem. Soc., 42, 615-619 (1920).
23. Zhang G. H., Wang Q., Chen J. J., Zhang X. M., Tam S. C., Zheng Y. T., Biochem. Biophys. Res. Commun., 334, 812-816 (2005).
24. Zheng Y. T., Zhang W. F., Ben K. L., Wang J. H., Immunopharmacol. Immunotoxicol., 17, 69-79 (1995).
25. Wang Q., Ding Z. H., Liu J. K., Zheng Y. T., Antiviral Res., 64, 189-194 (2004).